NABRIVA THERAPEUTICS AG shareholder history

Current and past NABRIVA THERAPEUTICS AG shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
Boxer Capital, LLC 880.16%0.78%1.55%Q4 2015Q3 20178
EcoR1 Capital, LLC 770.50%1.78%3.61%Q3 2015Q1 20177
Omega Fund Management, LLC 775.54%6.63%8.94%Q3 2015Q1 20177
WELLINGTON MANAGEMENT GROUP LLP 770.00%0.01%0.01%Q3 2015Q1 20177
Orbimed Advisors 770.10%0.13%0.23%Q3 2015Q1 20177
UNITED SERVICES AUTOMOBILE ASSOCIATION 770.00%0.00%0.00%Q3 2015Q1 20177
Novo Holdings A/S 770.70%1.19%2.97%Q3 2015Q1 20177
FRANKLIN RESOURCES INC 770.00%0.00%0.00%Q3 2015Q1 20177
Baker Brothers Advisors 770.02%0.03%0.03%Q3 2015Q1 20177
ACUTA CAPITAL PARTNERS, LLC 771.54%1.94%2.73%Q3 2015Q1 20177
Rock Springs Capital Management LP 770.17%0.24%0.36%Q3 2015Q1 20177
MORGAN STANLEY 770.00%0.00%0.00%Q3 2015Q1 20177
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 660.00%0.46%2.24%Q3 2015Q4 20166
Vivo Capital, LLC 666.46%8.86%14.20%Q1 2016Q2 20176
Tower Research Capital LLC (TRC) 310.00%0.00%0.00%Q3 2015Q1 20175
FT Options LLC 550.22%0.35%0.57%Q1 2016Q1 20175
MYCIO WEALTH PARTNERS, LLC 440.01%0.01%0.01%Q4 2015Q3 20164
Opaleye Management Inc. 440.88%1.16%1.53%Q4 2015Q3 20164
DEUTSCHE BANK AG\ 440.00%0.00%0.00%Q2 2016Q1 20174
Hillhouse Capital Management 330.09%0.12%0.16%Q4 2016Q2 20173
NEXT Financial Group, Inc 330.00%0.00%0.00%Q3 2016Q1 20173
UBS Group AG 210.00%0.00%0.00%Q4 2015Q4 20163
Tekla Capital Management LLC 220.09%0.10%0.11%Q4 2016Q1 20172
Polar Capital LLP 220.00%0.00%0.01%Q4 2015Q1 20162
Almanack Investment Partners, LLC. 220.91%1.16%1.40%Q1 2017Q2 20172
SPHERA FUNDS MANAGEMENT LTD. 220.21%0.22%0.22%Q3 2015Q4 20152
ROYAL BANK OF CANADA 220.00%0.00%0.00%Q4 2016Q1 20172
Commonwealth Equity Services, Inc 220.00%0.00%0.00%Q4 2016Q1 20172
MILLENNIUM MANAGEMENT LLC 220.00%0.00%0.00%Q3 2015Q4 20152
JACKSON PARK CAPITAL, LLC 220.24%0.25%0.27%Q2 2016Q3 20162
HIGHLAND CAPITAL MANAGEMENT LP 110.08%0.08%0.08%Q3 2015Q3 20151
Acrospire Investment Management LLC 110.00%0.00%0.00%Q2 2016Q2 20161
Anson Funds Management LP 110.05%0.05%0.05%Q4 2016Q4 20161
GEODE CAPITAL MANAGEMENT, LLC 110.00%0.00%0.00%Q1 2017Q1 20171
Renaissance Technologies 110.00%0.00%0.00%Q4 2016Q4 20161
ACADIAN ASSET MANAGEMENT LLC 110.00%0.00%0.00%Q1 2017Q1 20171
Alyeska Investment Group, L.P. 110.01%0.01%0.01%Q3 2015Q3 20151
BANK OF AMERICA CORP /DE/ 110.00%0.00%0.00%Q1 2016Q1 20161
Laurion Capital Management LP 110.00%0.00%0.00%Q3 2015Q3 20151
Nationwide Fund Advisors 110.01%0.01%0.01%Q1 2017Q1 20171
Catalyst Capital Advisors LLC 110.00%0.00%0.00%Q4 2015Q4 20151
External links

This page lists all the filers that currently own NABRIVA THERAPEUTICS AG or have owned NABRIVA THERAPEUTICS AG in the past.